Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Halozyme Therapeutics key operating metrics including Patents (Europe), environmental, and social and governance score (ESG).

Patents (Europe)

460
11.5%

FY, 2020

Patents (US)

43

FY, 2020

Phase II Trials Products

1

FY, 2020

Operating Metrics

MetricsFY, 2018FY, 2019FY, 2020
Patents (Europe)390520460
Patents (US)394343
Phase II Trials Products111
Products111
Partnered Products335
Phase III Trials Products538
Preclinical Phase Products2
Phase I Trials Products10910
Patent Applications 1007050
Filed Trials Products2

Environmental, Social and Governance (ESG)

Overall

50-59 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu